AMRI received a federal contract award from the National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) to provide chemistry and other drug discovery technologies to support NINDS’ Medicinal Chemistry for Neurotherapeutics Program (MCNP). AMRI will begin providing medicinal chemistry services to neuroscientists throughout the U.S. with the goal of efficiently developing preclinical drug candidates suitable for advanced development and ultimately clini...